Design and Evaluation of Patches for Transdermal Delivery of Losartan Potassium

References

1. 1.↵
   1. Chein Y.

   Novel Drug Delivery Systems; Marcel Dekker, Inc.: New York, 1992; Vol. 50, p 301.

   OpenUrl
2. 2.↵
   1. Kanikannan N.,
   2. Andega S.,
   3. Burton S.,
   4. Babu R. J.,
   5. Singh M.

   Formulation and in vitro evaluation of transdermal patches of melatonin. Drug Dev. Ind. Pharm. 2004, 30 (2), 205–212.

   OpenUrlPubMed
3. 3.↵
   1. Kydonieus A. F.,
   2. Berner B.

   Transdermal Delivery of Drugs; R.C. Press: Boca Raton, FL, 1987; pp 69–77.
4. 4.↵
   1. Blank I. H.

   Cutaneous barrier. J. Invest. Dermatol. 1965, 45, 240–256.

   OpenUrl
5. 5.↵
   1. Barry B. W.

   Dermatological Formulations: Percutaneous Absorption; Marcel Decker: New York and Basel, 1983; pp 261–262.
6. 6.↵
   1. Potts R. O.,
   2. Guy R. H.

   A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharm. Res. 1995, 12 (11), 1628–1633.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Panchagnula R.

   Transdermal drug delivery of tricyclic antidepressants: feasibility study. STP Pharm. Sci. 1996, 6 (6), 441–444.

   OpenUrl
8. 8.↵
   1. Stott P. W.,
   2. Williams A. C.,
   3. Barry B. W.

   Characterization of complex coacervates of some tricyclic antidepressants and evaluation of their potential for enhancing transdermal flux. J. Controlled Release 1996, 41 (3), 215–227.

   OpenUrl
9. 9.↵
   Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th ed.; Medical Publishing Division: New York, 2001; pp 448–449.
10. 10.↵
    1. Das M. K.,
    2. Bhattacharya A.,
    3. Ghosal S. K.

    Transdermal delivery of trazodone hydrochloride from acrylic films prepared from aqueous latex. Indian J. Pharm. Sci. 2006, 68 (1), 41–46.

    OpenUrl
11. 11.↵
    1. Das M. K.,
    2. Bhattacharya A.,
    3. Ghosal S. K.

    Transdermal delivery of trazodone hydrochloride from acrylic films prepared from aqueous latex, Indian J. Pharm. Sci. 2006, 68 (1), 41–46.

    OpenUrl
12. 12.↵
    1. Murthy T. G. K.,
    2. Mallikarjuna P.,
    3. Murali K.

    Design and development of piroxicam transdermal films. The Pharma Review 2004, 12, 145–147.

    OpenUrl
13. 13.↵
    1. Pandit V.,
    2. Khanum A.,
    3. Bhaskaran S.,
    4. Banu V.

    Formulation and evaluation of transdermal films for the treatment of overactive bladder. Int. J. Pharm. Tech. Res. 2009, 1 (3), 799–804.

    OpenUrl
14. 14.↵
    1. Aulton M. E.

    Pharmaceutics: The Science of Dosage Form Design, 2nd ed.; Aulton M. E. , Ed.; Churchill Livingstone: New York, 2002; pp 487– 488, 492–495.
15. 15.↵
    1. Sumanta M. K.,
    2. Dube R.,
    3. Suresh B.

    Transdermal drug delivery system of a haloperidol to overcome self-induced extrapyra-midal syndrome. Drug. Dev. Ind. Pharm. 2003, 29 (4), 405–415.

    OpenUrlPubMed
16. 16.↵
    1. Gattani S. G.,
    2. Gaud R. S.,
    3. Chaturvedi S. C.

    Formulation and evaluation of transdermal films of chlorpheniramine maleate. Indian Drugs 2007, 44, 27–33.

    OpenUrl
17. 17.↵
    1. Bharkatia M.,
    2. Nema R. K.,
    3. Gupta G. D.,
    4. Gaud R. S.

    Design and evaluation of propranolol hydrochloride transdermal patch. The Pharma Review 2005, 3, 113–116.

    OpenUrl
18. 18.↵
    1. Stoughton R. B.,
    2. Fritsch W.

    Influence of dimethyl sulfoxide on human percutaneous absorption. Drug. Dev. Ind. Pharm. 2003, 29 (4), 405–407.

    OpenUrlPubMed
19. 19.↵
    1. Gupta P. S.,
    2. Jain S. K.

    Effective and controlled transdermal delivery of metoprololtratarate. Indian J. Pharm. Sci. 2005, 67 (3), 346–350.

    OpenUrl
20. 20.↵
    1. Kulkarni R. V.,
    2. Mutalik S.,
    3. Hiremath D.

    Effect of plasticizers on the permeability and mechanical properties of eudragit films for transdermal application. Indian J. Pharm. Sci. 2002, 64 (1), 28–31.

    OpenUrl
21. 21.↵
    1. Rao R. P.,
    2. Divan P. V.

    Influence of casting solvent on permeability of ethyl cellulose free films for transdermal use. East Pharma. 1997, 40, 135–137.

    OpenUrl
22. 22.↵
    1. Panchagnula R.,
    2. Salve P. S.,
    3. Thomas N. S.,
    4. Jain A. K.,
    5. Ramarao P.

    Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int. J. Pharm. 2001, 219 (1–2), 95–105.

    OpenUrlPubMed
23. 23.↵
    1. Qvist M. H.,
    2. Hoeck U.,
    3. Kreilgaard B.,
    4. Madsen F.,
    5. Frokjaer S.

    Evaluation of G inverted question markttingenminipig skin for transdermal in vitro permeation studies. Eur. J. Pharm. Sci. 2000, 11, 59–68.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Landgraf W.,
    2. Li N.-H.,
    3. Benson J. R.

    New polymer enables near zero-order release of drugs. Drug Delivery Technol. 2005, 5 (2), 48–55.

    OpenUrl
25. 25.↵
    1. Brahmankar D. M.,
    2. Jaiswal S. B.

    Biopharmaceutics and Pharmacokinetics: A Treatise, 1st ed.; VallabhPrakashan: New Delhi, 1995; p 335.
26. 26.↵
    1. Suvakanta D.,
    2. Narasimha M. P.,
    3. Lilakanta N.,
    4. Chowdhry P.

    Kinetic modeling on drug release from drug delivery systems. ActaPoloniaePharmaceutica Drug Research 2010, 67 (3), 217–223.

    OpenUrl
27. 27.↵
    1. Sankar V.,
    2. Johnson D. B.,
    3. Sivanad V.,
    4. Ravichadran V.,
    5. Raghuram S.

    Design and evaluation of nifedipine transdermal patches. Indian J. Pharm. Sci. 2003, 65 (5), 510–515.

    OpenUrl
28. 28.↵
    1. Vogel H. G.

    Drug Discovery and Evaluation: Pharmacological Assays, 2nd ed.; Springer Publication: New York, 2002; pp 172–173.